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Abstract
A total of 107 Shiga toxin-producing Escherichia coli strains (STEC) isolated from
different origins in Sa˜o Paulo, Brazil, and belonging to different serotypes were
characterized regarding stx subtypes and susceptibility to antimicrobial agents.
Most of the human STEC strains harbored stx1 (85.7%), while stx2, associated or
not to stx1, was identified preferentially in the animal and food strains. None of the
STEC strains carried stx1c. Some genotypes occurred exclusively among strains of
bovine origin as stx2c, stx11212c (16.5% each), and stx2d (0.9%), whereas
stx212c(2vha) was only identified among the O157:H7 human strains. Moreover,
the stx2c(2vhb) subtype was found more frequently among bovine than human
strains (39% vs. 4.8%). The highest frequencies of susceptibility to antimicrobial
agents were observed among bovine (87%) and food (100%) STEC strains, while
47.6% of the human isolates were resistant to at least one drug. Multiresistance
occurred among O111 STEC strains from human and bovine origin. The
antimicrobials to which resistance was most frequently observed were tetracycline
(90%) and streptomycin (75%) among human strains, and also sulphazotrin
(88%) in animal strains. A few serotypes were commonly identified among STEC
strains isolated from diverse sources in Brazil, but in general the strains presented
distinct stx subtypes and/or antimicrobial resistance profiles.
Introduction
Shiga toxin-producing Escherichia coli (STEC) constitutes a
significant group of emerging enteric pathogens. STEC can
cause a wide range of human clinical symptoms including
diarrhea, hemorrhagic colitis (HC) and hemolytic uremic
syndrome (HUS) (Karmali, 1989; Paton & Paton, 1998).
Human infection with STEC follows exposure to the patho-
gen in contaminated food or water, or through contact with
animal feces. The intestinal tract of ruminants, in particular
cattle, has long been regarded as the principal reservoir of
STEC (Paton & Paton, 1998).
The main virulence properties in the pathogenesis of
HUS and HC are considered to be the Shiga toxins (Stx1
and Stx2), and different subtypes of Stx1 and Stx2 (stx1c,
stx2c, stx2d, stx2e, stx2f, stx2g) have been described already
(Weinstein et al., 1988; Tyler et al., 1991; Gannon et al.,
1992; Pie´rard et al., 1998; Schmidt et al., 2000; Leung et al.,
2003). However, some stx subtypes seem to occur more
frequently in animals than in humans (Brett et al., 2003a).
The presence of stx2 and stx2c has been associated with a
greater severity of human disease (Eklund et al., 2002;
Friedrich et al., 2002), while others are apparently of lesser
clinical significance. Therefore, information about the stx2
allele has considerable predictive value to assess the risk of
HUS development in a patient that presents STEC infection
(Friedrich et al., 2002).
One of the most controversial areas in the management of
STEC infections is related to the possible role of antimicro-
bials in the natural course of the infection (Yoh & Honda,
1997; Igarashi et al., 1999). As antimicrobials may cause the
lysis of bacterial cell walls, with the liberation of Stx, and/or
the increased expression of stx genes in vivo, they are not
recommended for treating STEC infections. Many STEC
isolates are susceptible to numerous antimicrobials, but
recent reports indicate that antimicrobial resistance of STEC
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is increasing (Zhao et al., 2001; White et al., 2002). Multiple
resistance to streptomycin, sulfamethoxazole and tetracy-
cline was most often observed.
Several studies conducted in the last few years in Brazil
have demonstrated the occurrence of important STEC
strains as cause of human disease including bloody diarrhea,
hemolytic anemia and HUS (Guth et al., 2002b, 2005; Irino
et al., 2002; Vaz et al., 2004; K. Irino et al., unpublished
data), as well as the prevalence of STEC strains in the animal
reservoir, especially bovines (Leomil et al., 2003; Irino et al.,
2005).
In this study, we analyzed the STEC strains previously
isolated in Sa˜o Paulo, Brazil from human infections, cattle
and foods in regard to their stx subtypes and antimicrobial
resistance profiles. Comparison of serotypes of the STEC
strains isolated from diverse sources was also carried out.
Materials and methods
Bacterial strains
One hundred and seven STEC strains previously isolated in
Sa˜o Paulo, Brazil were investigated in this study. Forty-two
STEC strains were isolated from human infections (Guth
et al., 2002a, b; Irino et al., 2002; Vaz et al., 2004), 61 were
from dairy and beef cattle (Leomil et al., 2003; Irino et al.,
2005), and four were from ground meat samples (Bergamini
et al., 2004).
stx1 and stx2 subtyping
The presence of stx1 and stx2 sequences was confirmed by
PCR with specific primers (Pollard et al., 1990). A restriction
fragment length polymorphism (RFLP)-PCR system using
specific primer pairs was employed for stx1 and stx2 subtyp-
ing. Briefly, the Gannon F-Gannon R primer pair was used
to amplify a 603 bp DNA fragment specific of the genes
coding for the stx1 and stx1c subtypes, and restriction
patterns were obtained using the restriction endonucleases
CfoI and RsaI (Brett et al., 2003b). The VT2c-VT2d primer
pair was used to amplify a 285 bp DNA fragment specific of
the genes coding for the stx2, stx2vh-a, stx2vh-b, and stx2-NV206
subtypes, and restriction patterns were obtained by HaeIII,
NciI, and RsaI. The VT2e-VT2f primer pair was used to
amplify a 348 bp DNA fragment specific of the genes coding
for the stx2d group (stx2d-OX3a, and stx2d-Ount), and restric-
tion patterns were obtained by HaeIII and PvuI (Tyler et al.,
1991; Pie´rard et al., 1998; Bertin et al., 2001). The Escherichia
coli control strains used were as follows: C600J (stx1), E123/2
(stx1c), C600W (stx2), 92-3580 (stx2vh-a), 93-016 (stx2vh-b),
EH250 (stx2d) and K12H5 (negative control).
Susceptibility to antimicrobial agents
Susceptibility to antimicrobial agents was determined by the
standard disk diffusion method (NCCLS, 1997) using the
following antimicrobials: amikacin (AM), ampicillin (A),
cefepime (Cpm), gentamicin (G), imipenem (Ipm), chlor-
amphenicol (C), streptomycin (S), ceftriaxone (Cro), cipro-
floxacin (Cip), cefoxitin (Cx), sulphazotrin (Sut),
kanamicin (K), tobramicin (Tb) and tetracycline (T).
Results and discussion
The stx1, stx2, stx2c, and stx2d subtypes isolated or combined
occurred in varied frequencies among the 107 STEC strains
studied, but stx1 and stx1stx2 genotypes prevailed, and were
identified in 42 (39.2%) and 20 (18.7%) of the strains,
respectively (Table 1). Analysis of the stx genotype distribu-
tion in correlation with the origin of the strains demon-
strated that stx1 prevailed among strains from human origin
(85.7%), while stx2 associated or not to stx1 was identified
preferentially in the animal and meat ground strains.
Furthermore, stx2c, stx2d and stx11212c genotypes occurred
exclusively among STEC strains from bovine origin. More-
over, the stx2c(2vhb) subtype was found more frequently
Table 1. Distribution of stx genotypes among STEC strains isolated in Sao Paulo, Brazil, from human infections, bovine and food sources
Origin No. of strains
No. (%) of STEC strains with stx genotype
1 2 2c 2d 112 112c 212c 11212c
Human 42 36 (85.7) 0 0 0 0 3w 3‰ 0
Cattle 61 6 7 10 (16.4) 1 19 (31.1) 2z 6z 10k (16.4)
Ground meat 4 0 3 (75) 0 0 1 0 0 0
Total (%) 107 42 (39.2) 10 10 1 (0.9%) 20 (18.7) 5 9 10
Two strains presented 2vha; seven strains were 2vhb; and one strain 2vha12vhb.
wOne strain presented 2vha; and two stains were 2vhb.
z2vhb.
‰2vha.
z2vhb.
kTwo strains presented 2vha; eight strains were 2vhb.
STEC, Shiga toxin-producing Escherichia coli.
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among bovine than in human strains (39% vs. 4.8%), while
similar frequencies on the stx2c(2vha) distribution were
identified (8.2% vs. 9.5%). All STEC strains from human
origin belonging to O157:H7 serotype presented the
stx2stx2c(2vha) genotype, whereas stx2stx2c(2vhb) occurred in
bovine strains belonging to other serotypes (O44:H25,
O105:H18, O113:H21) (data not shown). None of the STEC
strains carried stx1c, and stx2d was only identified in one
bovine STEC strain belonging to serotype O87:H16 (data
not shown).
Seventy-nine of the 107 (73.8%) STEC strains were
sensitive to all the 14 antimicrobial agents tested. The
highest frequencies of susceptibility were observed among
bovine (53/61, 87%) and food (100%) strains, while 20 of
the 42 (47.6%) human isolates were resistant to at least one
drug. Resistance was identified in some particular STEC
serotypes such as O26:H11, O111:H8, O111:H11,
O111:HNM, O118:H16, ONT:H2 and ONT:H49, but multi-
resistance occurred among O111 STEC strains from human
and bovine origins, and one human strain belonging to
serotype ONT:H2 (Table 2). The antimicrobial agents in
which resistance was most frequently observed were tetra-
cycline (90%) and streptomycin (75%) among human
strains, and also sulphazotrin (87.5%) among the bovine
strains (Table 2).
Different designations for the same stx genes have been
used in the literature causing some confusion, and making it
difficult to compare data from different geographic areas.
Nevertheless, for the first time a diversity of stx genotypes
has been described in STEC strains isolated from diverse
sources in Brazil.
The results presently obtained showed that most of the
Brazilian human strains carried only stx1, whereas stx2c, stx2d
and stx11212c genotypes were exclusively identified among
STEC strains from bovine origin. Although the prevalence of
stx1 among human strains may partially explain the mild
outcome of STEC infections identified in our community,
strains harboring stx1 had already been isolated from
patients with HUS and hemolytic anemia (Guth et al.,
2002b, 2005). Moreover, in agreement with studies that
correlate stx2 and/or stx2c with more severe human diseases
(Eklund et al., 2002; Friedrich et al., 2002), the stx2stx2c
genotype was observed in only three human strains, all
belonging to O157:H7 serotype, two of them being isolated
from patients with bloody diarrhea (Irino et al., 2002). It is
also interesting to mention that among the STEC strains
harboring stx2c identified in the present study, the 2vh-b
variant prevailed among animal strains. This result is con-
sistent with previous reports related to bovine non-O157
STEC (Bertin et al., 2001; Brett et al., 2003a; Girardeau et al.,
2005). The stx2d subtype was rarely detected among isolates
included in the present report (0.9%). In the literature, stx2d
has been predominantly identified among STEC strains
isolated from ovine sources (Ramachandran et al., 2001;
Zweifel et al., 2004), but its occurrence among some bovine
STEC strains has also been described (Brett et al., 2003a). In
relation to humans, stx2d is not recovered from feces of
patients with HC and HUS, but isolated from patients with
uncomplicated diarrhea or from asymptomatic carriers
(Eklund et al., 2002; Friedrich et al., 2002).
Monitoring the susceptibility of STEC strains to antimi-
crobial agents is an important issue to control the emergence
and dissemination of resistance, and to assess the role of
animals as the source of infection of resistant strains to
humans. Although O157:H7 strains were initially found to
be susceptible to several antimicrobials (Kim et al., 1994;
Table 2. Relationship between serotypes, stx genotypes and antimicro-
bial resistance profiles among STEC strains isolated from different origins
in Brazil
Serotype
Origin (no.
of strains)
stx
genotype
Antimicrobial
profile
O26:H11 H 1 T
H 1 ST
H (3) 1 –
O77:H18 H 112c –
B (2) 112 –
O93:H19 H 112c –
F 2 –
O111:H8 H (5) 1 –
H (2) 1 T
H 1 ST
H 1 SutT
B 1 SutT
B (3) 1 ASKSutT
H 1 ASCSutT
H 1 ASCKSutT
O111:H11 H 1 ST
O111:HNM H 1 T
H (2) 1 ST
H 1 SK
H 1 SCK
H (2) 1 SKT
B (3) 1 SSutT
H 1 SCSutT
H 1 SGKSutT
O118:H16 H 1 ST
H 1 –
O157:H7 H (3) 212cw –
B 2cw –
ONT:H2 H 1 ASKT
ONT:H49 B 112 T
ONT:HNT B (2) 112 –
F 112 –
2vh-b subtype.
w2vh-a subtype.
ONT, nontypable; HNM, nonmotile; HNT, nontypable; H, human;
B, bovine; F, ground meat; –, sensitive; A, Ampicillin; S, Streptomycin;
G, Gentamicin; C, Chloramphenicol; K, Kanamicin; Sut, Sulphazotrin;
T, Tetracycline; STEC, Shiga toxin-producing Escherichia coli.
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Schmidt et al., 1998), several recent studies have documen-
ted antimicrobial resistance among O157 and non-O157
STEC strains (Zhao et al., 2001; Khan et al., 2002; Maidhof
et al., 2002; Mora et al., 2005).
To our knowledge, this is the first report on the anti-
microbial resistance profiles of STEC strains isolated from
humans and food animals in Brazil. The data obtained
showed that 73.8% of the STEC strains were sensitive to all
the antimicrobials tested, consistent with results from
studies conducted in different countries (Pradel et al., 2000;
Eklund et al., 2001; Bettelheim et al., 2003). Curiously, the
highest frequency (47.6%) of resistance was found among
the human STEC strains, in contrast to the results described
by Schroeder et al. (2002), who detected a higher level of
resistance among cattle non-O157 STEC strains than among
human strains, but in agreement with the results observed
by Pradel et al. (2000) and Mora et al. (2005). Although
resistance was observed in some particular serotypes, multi-
drug resistance (three to six antimicrobials) was only
identified among O111:H8(NM) STEC strains from human
and bovine origins, and in one human ONT:H2 strain.
Multiple resistance among O111 STEC strains has been
reported by several authors (Zhao et al., 2001; White et al.,
2002; Mora et al., 2005), and as identified in the present
study the majority of isolates displayed resistance to strep-
tomycin, sulfamethoxazole, tetracycline and kanamicin.
A multiresistant clone of O118:H16 STEC was detected in
cattle and humans in different European countries (Maidhof
et al., 2002), and was also isolated from a 1-month-old calf
with diarrhea in Sa˜o Paulo, Brazil, suggesting the global
spread of this new emerging pathogen (Pestana de Castro
et al., 2003). Nevertheless, the presence of this multiresistant
clone was not identified among the O118:H16 STEC strains
from human origin analyzed in this study.
It should also be emphasized that none of the O157:H7
strains studied herein presented resistance to antimicrobials,
in contrast to the observations of Keskima¨ki et al. (1998),
who found that 64% of the human STEC strains isolated in
Finland, which were resistant to drugs, belonged to
O157:H7 serotype. Similarly, Meng et al. (1998) reported
that 43% of the O157 strains, isolated from animals, meat
samples and human origins, were resistant to antimicro-
bials, being the highest percentage (34%) found in strains
from bovine origin.
In this study, we also compared the serotypes of the STEC
strains isolated from different sources in Brazil, and verified
that a greater diversity was detected among bovine strains
(Leomil et al., 2003; Irino et al., 2005), that differed in
general from the restricted number of serotypes presented
by the STEC strains isolated from human infections (Guth
et al., 2002a, b, 2005; Vaz et al., 2004; K. Irino et al.,
unpublished data). However, some common serotypes
[O77:H18, O93:H19, O111:H8 (NM), O157:H7 and
ONT:HNT] occurred among STEC strains from different
origins. The subtyping of these O77:H18, O93:H19 and
O157:H7 strains by pulsed-field gel electrophoresis (PFGE)
showed that identical PFGE profiles were displayed by two
O77:H18 STEC strains isolated from cattle. Indistinguish-
able PFGE patterns were observed in two O157:H7 strains
isolated from human infections, although these only showed
70% of similarity to the bovine O157:H7 strain. The genetic
similarity of the human O77:H18 strain and the two
O93:H19 strains isolated from human and food could not
be analyzed because no banding patterns were defined (Vaz
et al., 2006). Therefore, the presence of some particular
clones could be observed among human STEC strains and in
the animal reservoir.
In summary, the data from this study suggest that STEC
strains isolated from cattle seem not to present a high risk of
spreading antibiotic-resistant strains to humans in the Sa˜o
Paulo setting. However, more extensive studies in different
food animal populations are necessary to confirm this
hypothesis. Moreover, STEC strains circulating and causing
disease in humans in our community belong to a restricted
number of serotypes and, in general, present distinct stx
subtypes and/or antimicrobial resistance profiles from those
identified among STEC strains isolated from the environ-
ment. This could be one of the reasons why STEC has not yet
become a major problem in Brazil.
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